Kane Biotech was preparing the annual financial statements and, as part of the year$-$end procedures, assessed the assets and

prepared the following alphabetized schedule based on adjusted values at December $31,2023$: $($Do not round intermediate

calculations. Round final answers to nearest whole dollar.$)$

$*$DDB $=$ Double$-$declining$-$balance; SL $=$ Straight$-$line; Units $=$ Units$-$of$-$production; N$/$A $=$ Not applicable

Required:

Record any impairment losses at December $31,2023.$ Assume Kane Biotech has recorded no impairment losses in previous

years.

$2.$ Record depreciation for each asset at December $31,2024.$ Assume that there was no change in the residual values or useful lives regardless of any impairment losses that might have occurred. The equipment produced $2,150$ units during $2024.$